Webinar Date/Time: Tue, Jun 4, 2024 9:00 AM EDT
In the fast-paced world of pharmaceuticals, it is crucial for injectable drug developers to stay informed about the ever-changing requirements set forth by regulatory authorities. In this webinar, industry experts will educate the audience about the latest updates to USP and EU GMP requirements, and will explain how to confidently navigate the complexities of injectable drug regulations.
Register Free: https://www.pharmtech.com/pt_w/regulatory-requirements
Event Overview:
In the fast-paced world of pharmaceuticals, it is crucial for injectable drug developers to stay informed about the ever-changing requirements set forth by regulatory authorities. These updates not only ensure enhanced patient safety, but also help maintain strict adherence to standards when prescribing or administering injectable medications. In this webinar, industry experts will educate the audience about the latest updates to USP and EU GMP requirements, and will explain how to confidently navigate the complexities of injectable drug regulations.
Key Learning Objectives:
Who Should Attend:
Speaker:
Tabassam Sharif
Manager Regulatory Affairs
Datwyler
Tabassam Sharif, an experienced Manager of Regulatory Affairs at Datwyler since 2018, brings a wealth of knowledge and expertise to the pharmaceutical industry. With a Master's degree in Natural Sciences and 15 years of experience in Regulatory Affairs, Tabassam is well-versed in the intricacies of navigating drug regulations. In his current role, he holds global responsibility for submitting and updating Drug Master Files with health authorities, providing invaluable support to pharmaceutical companies seeking regulatory approvals. Additionally, Tabassam actively contributes to standardization efforts as a member of various esteemed groups, including the Ph. Eur. experts Group 16, ISO Technical Committee 76 / WG4, and the PDA Task Force on TR 73-2. His extensive involvement in these initiatives further showcases his commitment to staying at the forefront of regulatory advancements.
Register Free: https://www.pharmtech.com/pt_w/regulatory-requirements
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.